Korea Centers for Disease Control and Prevention, Cheongju, Republic of Korea
Copyright © 2015 Korea Centers for Disease Control and Prevention. Published by Elsevier Korea LLC. All rights reserved.
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License (http://creativecommons.org/licenses/by-nc-nd/4.0) which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
Characteristics | No. of patients |
---|---|
Sex, n (%) | |
Male | 111 (59.7) |
Female | 75 (40.3) |
Age (y), median (IQR) | 55 (42–66) |
≥65y, n (%) | 55 (29.6) |
Case classification, n (%) | |
Healthcare personnel | 25 (13.4) |
Patient | 82 (44.1) |
Caregiver | 61 (32.8) |
Others∗ | 18 (9.7) |
Symptoms at presentation, n (%) | |
Fever/chills | 138 (74.2) |
Cough | 33 (17.7) |
Dyspnea | 10 (5.4) |
Myalgia | 47 (25.3) |
Headache | 16 (8.6) |
GI symptoms† | 24 (12.9) |
Sputum | 14 (7.5) |
Sore throat | 8 (4.3) |
Comorbidities, n (%) | |
Any‡ | 102 (54.8) |
Respiratory disease§ | 23 (12.4) |
Diabetes mellitus | 52 (28.0) |
Cardiac disease∥ | 42 (22.6) |
Chronic kidney disease | 9 (4.8) |
Malignancy | 43 (23.1) |
Known setting of contact, n (%)¶ | |
Healthcare facility | 178 (98.0) |
Household | 1 (0.5) |
Ambulance | 3 (1.5) |
Time from symptom onset to laboratory confirmation in days, median (IQR) | 5 (3–9) |
Time from symptom onset to death in days, median (IQR) | 15 (10–20) |
Outcome as of July 13, 2015, n (%) | |
Recovered | 131 (70.4) |
Ongoing treatment in hospital | 19 (10.2) |
Died | 36 (19.4) |
† Any one or more among the following symptoms: nausea, vomiting, diarrhea, gastric discomfort, loss of appetite.
Patient number | 1 | 14 | 15 | 16 | 76 |
---|---|---|---|---|---|
Infected no. of patients | 28 | 85 | 6 | 23 | 11 |
Age (y) | 68 | 35 | 35 | 41 | 75 |
Sex | Male | Male | Male | Male | Female |
Body mass index | 27 | 30 | 24 | 24 | 19 |
Underlying disease | Hypertension, asthma | No | No | Familial adenomatous polyposis | Diabetes mellitus, multiple myeloma |
Exposed duration (d)∗ | 10 | 9 | 10 | 11 | 2 |
Exposed setting |
GW (27 cases) OPD (1 case) |
ER (78 cases) GW (4 cases) Other (3 cases) |
GW (6 cases) |
GW (22 cases) Other (1 case) |
ER (4 cases) GW (3 cases) Other (4 cases) |
Number of close contacts | 626 | 594 | 304 | 277 | 805 |
Personal protective equipment | No | Intermittent | No | No | No |
Pneumonia† | Present | Present | Present | Present | Present |
Cough | Frequent | Frequent | Rare | Frequent | Rare |
Prognosis | Survived | Survived | Survived | Survived | Expired |
Aerosol-generating procedure | No | No | No | No | No |
Variable |
Univariate logistic regression |
Multivariate logistic regression |
||||
---|---|---|---|---|---|---|
OR | 95%CI | p | OR | 95%CI | p | |
Sex, male | 1.44 | 0.67–3.11 | 0.434 | 1.56 | 0.62–3.91 | 0.33 |
Age, ≥ 65 y | 7.67 | 3.45–17.04 | <0.0001 | 4.86 | 1.90–12.45 | 0.001 |
Case classification, patient | 3.17 | 1.47–6.83 | 0.003 | 0.82 | 0.27–2.50 | 0.73 |
Respiratory disease∗,† | 6.27 | 2.48–15.83 | <0.0001 | 4.90 | 1.64–14.65 | 0.004 |
Diabetes mellitus | 2.91 | 1.436–6.20 | 0.006 | 1.37 | 0.55–3.45 | 0.49 |
Cardiac disease† | 4.43 | 2.02–9.70 | <0.0001 | 2.21 | 0.86–5.67 | 0.09 |
Chronic kidney disease | 5.84 | 1.48–23.0 | 0.012 | 2.30 | 0.44–11.94 | 0.32 |
Malignancy | 2.63 | 1.20–5.76 | 0.015 | 1.92 | 0.75–4.86 | 0.16 |